Vaping Related Lung Injuries: October 17 Update

What to know about the outbreak of vaping-linked illness and deaths

Since August, there has been a multistate outbreak of lung disease in the U.S. associated with e-cigarette product use.  The Centers for Disease Control and Prevention (CDC), the U.S. Food and Drug Administration (FDA), state and local health departments and other clinical and public health partners are investigating these cases of e-cigarette, or vaping, product use associated lung injury (EVALI).  


The CDC provides Recommendations for Clinicians, which encourage physicians to report possible cases of e-cigarette or vaping-associated pulmonary disease to their local or state health department.


While the exact cause of the vaping-induced lung injury producing these illnesses remains unknown, radiologists are being asked to review medical images related to possible cases.


A Special Interest Session will be held at RSNA 2019 on Monday, Dec. 2 at 4:30 p.m. Add Hot Topic: Vaping Associated Lung Injury to My Agenda. 


Jeffrey S. Klein, MD, RSNA Board member and thoracic radiologist at the University of Vermont, explains what radiologists should know to date: 


According to the CDC:

  • There are 1,479 confirmed and probable cases of lung illness reported from 49 states and one U.S. territory as of Oct. 15. 
  • 33 deaths have been reported from 24 states.
  • All reported cases have a history of e-cigarette product use or vaping.
  • Most patients have reported a history of using e-cigarette products containing THC. Many patients have reported using tetrahydrocannabinol (THC) and nicotine. Some have reported the use of e-cigarette products containing only nicotine.

For More Information

The CDC website provides additional information about e-cigarette use and associated illnesses.